BLCAP and neoplasm: Specimens with tumor cells displaying marked nuclear immunoreactivity for BLCAP were also observed in 19% (19 out of 101; with 1% or more cells having nuclear staining) of the tumor specimens examined (Fig. 2E, red arrow).